Court says runner Caster Semenya can appeal testosterone limit for female athletes
Sign up now: Get the biggest sports news in your inbox
South Africa's Caster Semenya has a medical condition known as hyperandrogenism, which is characterised by higher than usual levels of testosterone.
PHOTO: AFP
STRASBOURG, France – Europe’s top human rights court ruled in favour of Olympic runner Caster Semenya on Tuesday, saying courts in Switzerland should give her a new chance to fight a requirement that female athletes with high natural testosterone take drugs to lower it.
The South African double Olympic 800m champion, 32, had approached the European Court of Human Rights (ECHR) in February 2021 after losing appeals to the Court of Arbitration for Sport (CAS) – sport’s highest court – and the Swiss Federal Tribunal (SFT) in a long-running legal battle.
The ECHR ruled, by a slender majority of four votes to three, that Semenya’s original appeal against World Athletics regulations had not been properly heard.
“The Court found in particular that the applicant had not been afforded sufficient institutional and procedural safeguards in Switzerland to allow her to have her complaints examined effectively,” ECHR said in a statement.
“The high stakes of the case for the applicant and the narrow margin of appreciation afforded to the respondent State should have led to a thorough Institutional and procedural review, but the applicant had not been able to obtain such a review.”
Semenya may now be free to challenge, once again, rules that have left her career on hold, but there is still some way to go.
During a three-month period following the ECHR judgment, it is not final and any party may request that the case be referred to the Grand Chamber of the Court.
If a request is made, a panel of five judges will consider whether it deserves further examination. The Grand Chamber will hear the case and deliver a final judgment.
World Athletics said it stood by its rules, which would remain in place for now, adding it would encourage the Swiss government to ask for a review of the judgment.
“We remain of the view that the differences in sexual development (DSDs) regulations are a necessary, reasonable and proportionate means of protecting fair competition in the female category as the CAS and SFT both found, after a detailed and expert assessment of the evidence,” World Athletics said in a statement.
“We will liaise with the Swiss government on the next steps and, given the strong dissenting views in the decision, we will be encouraging them to seek referral of the case to the ECHR Grand Chamber for a final and definitive decision.”
Semenya has a medical condition known as hyperandrogenism, which is characterised by higher than usual levels of testosterone, a hormone that increases muscle mass, strength and haemoglobin, which affects endurance.
In order to compete in women’s events, athletes with DSDs that result in high testosterone levels must lower them to those of “a healthy woman with ovaries”.
The CAS ruled in 2019 that World Athletics’ rules were necessary for fair female competition. Then, Semenya said the rules were discriminatory, and contraceptive pills made her feel “constantly sick”. She lost her appeal to the SFT in 2020 to set aside the CAS ruling.
Semenya won the women’s 800m gold at the 2012 London Olympics and at the 2016 Rio Games, and is also a three-time world champion in the distance.
The regulations, initially applied to races from 400m to a mile, were expanded in March to include all female track events, preventing Semenya from relaunching her career by running longer distances.
REUTERS
